Anthropic's Claude Science: Workflow Over New Model
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Anthropic introduced Claude Science on Tuesday as a workflow workbench, not a new model — it runs the same Claude models already available (including Claude Opus 4.8) with no special access or gating.
- Claude Science connects to 60+ scientific databases with pre-built toolkits for genomics, protein structure, and chemistry; a main AI assistant spawns sub-assistants, delegates to user-built "expert" assistants, and runs a fact-checker on citations and calculations before publication.
- The product builds on Anthropic's October 2025 Claude for Life Sciences launch and fits a broader push to own the "operating layer" for vertical industries the way Claude Code owns it for software development.
- Claude Science is in beta for Pro, Max, Team, and Enterprise subscribers; Novo Nordisk and Allen Institute are named as customer case studies, and the tool can run on a lab's own infrastructure rather than sending data to Anthropic's servers.
- OpenAI released GPT-Rosalind in April as a specialized biology model gated behind a qualification and safety review for enterprise customers, with early access partners including Amgen, Allen Institute, Moderna, Thermo Fisher, and Novo Nordisk.
- Google DeepMind takes a third route, leveraging proprietary foundational science models like AlphaFold and AlphaGenome through Gemini for Science, which bundles 30+ life science databases — assets no competitor can replicate.
- Anthropic will fund up to 50 Claude Science projects with up to $30,000 in credits; applications close July 15, 2026, notifications go out by July 31, and funded projects run September 1 to December 1, 2026.
Why it matters: Three of the largest AI labs are now converging on scientific research with fundamentally different distribution models: Anthropic goes wide with subscription access, OpenAI gates its biology model behind enterprise review, and Google leans on proprietary foundational models like AlphaFold nobody else has. The fact that Novo Nordisk and Allen Institute appear as customer case studies for BOTH Anthropic and OpenAI suggests the scientific AI market is fragmenting into multi-vendor relationships rather than winner-take-all competition.
